My passion is about inspiring pharma leaders to shift from just delivering messages to healthcare professionals to transforming and becoming their trusted advisers. Over the past three years, we’ve tackled the challenges of digital transformation in healthcare, and through these LinkedIn conversations, I want to spark connection, inspire change, and drive meaningful transformation that improves outcomes for healthcare professionals and their patients.
I was delighted to interview Carlos Eid, Executive Director, International Medical Affairs Cardiovascular with Novartis in June.
Introduction
Carlos is a medical director, a global pharmaceutical professional with over fourteen years of experience spanning medical affairs, market access and field medical excellence. He currently leads the cardiovascular medical affairs team for international markets, where he applies his expertise across diverse geographies. He is driven by the opportunity to make a meaningful impact on clinical practice and patient outcomes.
In his personal time, he enjoys writing and speaking with other leaders, and he likes to talk about leadership, field medical and the future of medical affairs. He’s a huge Lego fan, a musician and a father of two girls. We first met in-person on a panel at the NEXT Pharma Summit in Vienna.
Disclaimer: Carlos is representing his own views here, not his company.
